E. Lynne Kelley
Nessuna posizione attualmente
Posizioni attive di E. Lynne Kelley
| Società | Posizione | Inizio | Fine |
|---|
Storia della carriera di E. Lynne Kelley
Precedenti posizioni note di E. Lynne Kelley
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| X4 PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 25/04/2019 | 03/04/2020 |
| OCUGEN, INC. | Direttore Tecnico/Scientifico/R&S | 31/07/2018 | 23/01/2019 |
| BECTON, DICKINSON AND COMPANY | Corporate Officer/Principal | 01/02/2011 | 01/01/2016 |
| KIMBERLY-CLARK CORPORATION | Direttore Tecnico/Scientifico/R&S | 01/11/2007 | 01/12/2010 |
| BOSTON SCIENTIFIC CORPORATION | Direttore Tecnico/Scientifico/R&S | 01/01/2005 | 01/01/2007 |
| Yale University | Corporate Officer/Principal | 01/01/2003 | 01/01/2005 |
| SENSEONICS HOLDINGS, INC. | Direttore Tecnico/Scientifico/R&S | 01/01/2016 | - |
Formazione di E. Lynne Kelley
| Boston University | Undergraduate Degree |
| Dartmouth Medical School | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 9 |
| Israele | 2 |
Posizioni
| Chief Tech/Sci/R&D Officer | 6 |
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 5 |
| Consumer Services | 4 |
| Consumer Non-Durables | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 5 |
|---|---|
| BECTON, DICKINSON AND COMPANY | Health Technology |
| KIMBERLY-CLARK CORPORATION | Consumer Non-Durables |
| BOSTON SCIENTIFIC CORPORATION | Health Technology |
| SENSEONICS HOLDINGS, INC. | Electronic Technology |
| X4 PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Histogenics Corp.
 Histogenics Corp. BiotechnologyHealth Technology Histogenics Corp. engages in the development, marketing, and commercialization of restorative cell therapies. Its regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bioadhesives, and growth factors to provide solutions that can be utilized individually and in concert to treat musculoskeletal-related conditions. The company was founded on June 28, 2000 and is headquartered in Waltham, MA. | Health Technology |
- Borsa valori
- Insiders
- E. Lynne Kelley
- Esperienza
